BNTX: Biontech Se insider trading, 5% holders and institutional ownership

From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.

Insider trading

0 open-market buys totaling - and 13 sales totaling $39.92M in the last 180 days.

Insider sales

Trade dateInsiderRoleValue10b5-1 plan
2026-10-09Sahin UgurCEO$3.45Myes
2026-10-08Sahin UgurCEO$2.49Myes
2026-10-07Sahin UgurCEO$2.30Myes
2026-10-06Sahin UgurCEO$2.03Myes
2026-10-05Sahin UgurCEO$7.00Myes
2026-10-02Sahin UgurCEO$1.64Myes
2026-10-01Sahin UgurCEO$1.66Myes
2026-09-30Sahin UgurCEO$3.14Myes
2026-09-29Sahin UgurCEO$3.34Myes
2026-09-28Sahin UgurCEO$3.35Myes
2026-09-25Sahin UgurCEO$2.66Myes
2026-09-24Sahin UgurCEO$3.86Myes
2026-09-23Sahin UgurCEO$2.98Myes

Institutional ownership (Q2 2026)

283 institutions reported holding $4.10B of Biontech Se on Form 13F (274 the quarter before). 37 opened a new position and 31 sold out. Shares held by institutions: same.

Largest holdersSharesValue
FMR LLC7,571,805$704.56M
PRIMECAP MANAGEMENT CO/CA/3,772,031$350.99M
Dodge & Cox3,677,591$342.20M
FLOSSBACH VON STORCH SE2,226,138$207.14M
BlackRock, Inc.1,854,966$172.60M
Temasek Holdings (Private) Ltd1,506,027$140.14M
BNP PARIBAS FINANCIAL MARKETS1,319,517$122.78M
Logos Global Management LP1,015,000$94.45M
GSK plc889,824$82.80M
Assenagon Asset Management S.A.846,526$78.77M

Get new insider and activist filings the morning after: daily alerts. Not investment advice.